Arab Israeli Conflict
Middle East News
Hi Tech News
Mylan rejected Teva's $41 billion bid earlier this week.
Acquisition would create leading company with potential to transform global market for generics.
Teva sought stay of lower court ruling that favored developers of generic versions of its top selling multiple sclerosis drug.
The company making its first gesture, albeit a small one, to the workers and the Histadrut.
By GALI WEINREB/GLOBES
"Israel is poor in natural resources, but rich in human resources."
By GREER FAY CASHMAN
Teva has received some NIS 22 billion in tax breaks and grants over the past decade, without any conditions regarding layoffs in return.
By MAX SCHINDLER
There are some 1,780 Jerusalemites employed at the city’s two branches of Teva, which for decades has been one of the country’s greatest industrial success stories.
By PEGGY CIDOR
If done right, Israel could turn the Teva crisis from a misfortune into an opportunity.
By YAAKOV KATZ
Prime Minister Benjamin Netanyahu said that American Vice President Pence is “a great friend of Israel and a great friend of Jerusalem.”
By HERB KEINON
The Histadrut labor organization has called on workers across the country to power down machinery and walk out in protest of proposed cuts at Teva.
By MAX SCHINDLER,HERB KEINON,ERIC SUMNER
Teva has benefited from an estimated NIS 22 billion ($6.2b.) in tax breaks and subsidies from 2006 until today.
Prime Minister Benjamin Netanyahu called Teva's CEO Kare Schultz on Thursday.
Protesters blocked the gate to the pharmaceuticals factory.
By ALON HOCHMON/MAARIV,YUVAL BAGNO/MAARIV,MAX SCHINDLER,JPOST.COM STAFF
Please insert a valid email address